Flow cytometry with or without cytochemistry for the diagnosis of acute leukemias?

Communications in Clinical Cytometry

Volumn 34, Issue 2, 1998, Pages 82-86

  Kheiri, Samir A ^a   MacKerrell, Thomas ^a   Bonagura, Vincent R ^a   Fuchs, Alexander ^a   Billett, Henny H ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Cytochemistry; Flow cytometry; Leukemia

Indexed keywords

MONOCLONAL ANTIBODY;

ACUTE LEUKEMIA; ANTIBODY SPECIFICITY; ANTIGEN EXPRESSION; ARTICLE; BONE MARROW CELL; COST CONTROL; CYTOCHEMISTRY; FLOW CYTOMETRY; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; LEUKEMIA CELL; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

EID: 0032522857     PISSN: 01964763     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0320(19980415)34:2<82::AID-CYTO4>3.0.CO;2-E     Document Type: Article

References (24)

1. Browman GP, Neame PB, Soamboonsrup P: The contribution of cytochemistry and immunophenotyping to the reproducibility of the FAB classification in acute leukemia. Blood 68:900-905, 1986.
2. Bene MC, Castoldi G, Knapp W, Ludwig WD, Matutes E, Orfao A, van't Veer MB: Proposals for the immunological classification of acute leukemias. Leukemia 9:1783-1786, 1995.
3. Del Canizo C, San Miguel JF, Gonzalez M, Anta JP, Orfao A, Lopez-Borrasca A: Discrepancies between morphologic, cytochemical and immunologic characteristics in acute myeloid leukemia. Am J Clin Pathol 88:38-12, 1987.
4. Catovsky D, Matutes E: The classification of acute leukemia. Ann Hematol 62:16-21, 1991.
5. Paietta E, Andersen J, Wiernik PH: A new approach to analysing the utility of immunophenotyping for predicting clinical outcome in acute leukemia. Leukemia 10:14, 1996.
6. Wiersma SR, Ortega J, Sobel E, Weinberg KE Clinical importance of myeloid-antigen expression in acute lymphoblastic leukemia of childhood. N Engl J Med 324:800-808, 1991.
7. Drexler HG, Thiel E, Ludwig W: Review of the incidence and clinical relevance of myeloid antigen-positive acute lymphoblastic leukemia. Leukemia 5:637-645, 1991.
8. Sohol RE, Mick R, Royston I, Davey FR, Ellison RR, Newman R, Cuttner J, Griffin JD, Collins H, Nelson DA, Bloomfield CD: Clinical importance of myeloid antigenic expression in adult acute lymphoblastic leukemia. N EnglJ Med 316:1111-1117, 1987.
9. Cross AH , Goorha RM, Nuss R, Behm FG, Murphy SB, Kalwinsky DK, Raimondi S, Kitchingman GR Mirro J: Acute myeloid leukemia with T-lymphoid features: A distinct biologic and clinical entity. Blood 72:579-587, 1988.
10. Launder TM, Bray RA, Stempora I, Chenggis ML, Farhi DC: Lymphoid-associated antigen expression by acute myeloid leukemia. Am J Clin Pathol 106:185-191, 1996.
11. Stelzer GT, Shults KE, Loken MR: CD45 gating for routine flow cytometric analysis of human bone marrow specimens. Ann NY Acad Sci 677:265-280, 1993.
12. Borowitz MJ, Buenther KL, Shults KE, Stelzer GT: Immunophenotyping of acute leukemia by flow cytometric analysis. Use of CD45 and right angle light scatier to gate on leukemic blasts in three-color analysis. Am J Clin Pathol 100:534-540, 1993.
13. Horvatinovich JM, Sparks SD, Borowitz MJ: Detection of terminal deoxynucleotidyl transferase by flow cytometry: A three color method. Cytometry 18:228-230, 1994.
14. Bennet JM, Catovsky D, Daniel MT: Proposed revised criteria for the cliassificaiton of acute myeloid leukemia. A report of the French American British Group. Ann Intern Med 103:620-625, 1985.
15. Scott CS, Den Ottolandr GJ, Swirsky D, Pangalis GA, Vives Corrons JL, de Pasquale A, Van Hove L, Bennett JM, Namha K, Flandrin G: Recommended procedures for the classfication of acute leukemias. ICSH. Leuk Lymphoma 11:37-50, 1993
16. Paietta E, Anderson, J, Gallagher R, Benett J, Yunis J, Cassileth P, Rowe J, Wiernik PH: The immunophenotype of acute promyelocytic leukemia (APL): An ECOG study. Leukemia 8:1108-1112, 1994.
17. Erber WN, Asbahr H, Rule SA, Scott CS: Unique immunophenotype of acute promyelocytic leukemia as defined by CD9 and CD68 antibodies. Br J Haematol 88:101-104, 1994
18. LeBien TW, McKenna RW, Abramson CS, Gajl-Peczalska KJ, Nesbit ME, Cocia PF, Bloomfield CD, Brunning RD, Kersey JH: Use of monoclonal antibodies, morphology and cytocychemistry to probe the cellular heterogeneity of acute leukemia and lymphoma. Cancer Res 41:4776-4880, 1981.
19. Arbor DA, Glackin C, Lowe G, Medeiros LJ, Slovak ML: Presence of 1(8;21)(q22;q22) myeloperoxidase-positive, myeloid surface antigen negative acute myeloid leukemia. Am J Clin Pathol 107:68-73, 1997.
20. Matutes E, Morilla R, Farahat N, Carbonell F, Swansbury J, Dyer M, Catovsky D: Definition of acute biphenotypic leukemia. Hematolologia 82:64-66, 1997.
21. Drexler HG, Thiel E, Ludwig WD: Acute myeloid leukemias expressing lymphoid-associated antigens: Diagnostic incidence and prognostic significance Leukemia 7:489-498, 1993.
22. Wang JC, Beauregard P, Soamboonsrup P, Neame PB: Monoclonal antibodies in the management of acute leukemia. Am J Hematol 50:188-189, 1995.
23. Tallman MS, Andersen JW, Schiffer CA, Appelbaum FR, Feusner JH, Ogden A, Shepherd L, Willman C, Bloomfield CD, Rowe JM, Wiernik PH: Al trans retinoic acid in acute promyelocytic leukemia. N Engl J Med 337:1021-1028, 1997.
24. Raspadori D, Lauria F, Ventura MA, Rondelli D, Visani G, deVivo A, Tura S: Incidence and prognostic relevance of CD34 expression in acute myeloblastic leukemia: Analysis of 141 cases. Leuk Res 21:603-607, 1997.